The information on this website is intended to provide scientific information about Alkermes products and areas of therapeutic interest. Information may include data on investigational uses of approved or unapproved drugs for which safety and effectiveness have not been established. There is no guarantee that such uses will receive health authority approval and Alkermes does not recommend or suggest use of its medicines in a manner inconsistent with approved labeling.
This section includes selected Alkermes abstracts, posters or oral presentations, which have been accepted for congress presentations in the last 2 years. The content contained in this section is subject to congress copyright permissions.
David Plante,1 Ron Grunstein,2 Giuseppe Plazzi,3 Kiran Maski,4 Jandira Ramos,5 Yangchun Du,5 Alexandra Lovett,5 Marcus Yountz,5 Bhaskar Rege5
1University of Wisconsin School of Medicine and Public Health, Madison, WI, USA; 2Woolcock Institute of Medical Research, Macquarie University and Sydney Health Partners, Sydney, Australia; 3IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy; 4Department of Neurology, Boston Children’s Hospital, Boston, MA, USA; 5Alkermes, Inc., Waltham, MA, USA
